Vimovo: first NSAID–PPI combo now available in CanadaAstraZeneca introducing first fixed-dose combination product containing a nonsteroidal anti-inflammatory drug and proton pump inhibitor. Canada could learn from Kenyan HIV texting studyCanadian researcher says approach will also be assessed in British Columbia among low-income patients with HIV or TB Smoking cessation drug has promise in cardiac patients Ottawa researchers also report success with their program for quitting smoking Pharmetics recalls OTC products Pharmetics Inc. is voluntarily recalling selected lots of six OTC drugs from the Canadian market. New drug offers hope for triple-negative disease The new theory of (fee) relativity In Ontario, GPs are more comfortable. Other sections now have concerns but (mostly) accept the new process Canada should follow U.S. in using diabetes test Hemoglobin A1c test catches dysglycemia earlier than glucose test Sustained-release lithium back on the market AA Pharma introducing Lithmax (lithium carbonate 300 mg sustained-release tablets). CPhA, Aglukkaq hold first meeting MDs play trigger role in new health loyalty rewards strategy Imagine your patients receiving rewards for following your advice First Previous 1081 1082 1083 1084 1085 Next Last